bay-11-7082 and Ameloblastoma

bay-11-7082 has been researched along with Ameloblastoma* in 1 studies

Other Studies

1 other study(ies) available for bay-11-7082 and Ameloblastoma

ArticleYear
TNF-α-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT.
    Oral diseases, 2017, Volume: 23, Issue:2

    Ameloblastoma (AM) shows locally invasive behaviour. However, biological investigations regarding regulation of gene expression associated with AM pathological features are difficult to perform, because AM cells can be passaged for a few generations due to senescence. We report a newly established immortalized AM cell line, AMB cells, by transfection with human telomerase reverse transcriptase (hTERT). Furthermore, we examined whether TNF-α modulates bone resorption-related genes, IL-6 and MMP-9 in cooperation with TGF-β or IFN-γ.. Following transfection of an hTERT expression vector into AM cells using a non-viral method, the effects of cytokines on the expressions of IL-6 and MMP-9 mRNA were examined using real-time PCR. TNF-α-induced NF-κB activity was examined by western blotting and transcription factor assays.. AMB cells continued to grow for more than 100 population doublings. Stimulation with TNF-α increased IL-6 and MMP-9 mRNA expressions, as well as NF-κB activation. Furthermore, TGF-β and IFN-γ dramatically increased TNF-α-mediated expressions of MMP-9 and IL-6 mRNA, respectively, while those responses were suppressed by NF-κB inhibitor.. We established an immortalized AM cell line by hTERT transfection. TNF-α-mediated regulation of MMP-9 and IL-6 via NF-κB may play an important role in the pathological behaviour of AMs, such as bone resorption.

    Topics: Adult; Ameloblastoma; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Female; Gene Expression; Humans; Interferon-gamma; Interleukin-6; Jaw Neoplasms; Matrix Metalloproteinase 9; NF-kappa B; Nitriles; RNA, Messenger; Sulfones; Telomerase; Transfection; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2017